Use of Biocellular and cellular approaches to treatment of Osteoarthritis (OA), musculoskeletal aging processes, pain, and degenerative changes are to be studied with minimally invasive protocols, and non-pharmaceutical means to relieve OA and its associated issues. Traditional surgical interventions have not yielded convincing long-term outcomes, including total joint replacement surgeries and medical management of the supportive structures. This study is to use a person's own stem/stromal Cells (autologous) plus HD-PRP (important healing growth factors and signal molecules) in such cases of OA for long-term minimally invasive treatments. Baseline (existing) findings are documented, and thence tracked as to progress deemed to be result of the intervention.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Participant with Complications
Timeframe: 6 Months
Numeric Pain Rating Scale (NPRS)
Timeframe: 6 months
Changes from Baseline visual analog pain scale (VAS)
Timeframe: Baseline, 1 month, 6 months, 1 year
Changes in Ultrasound Images from Baseline Condition
Timeframe: Baseline, 6 months, 1 year